United Therapeutics (UTHR) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

For the quarter ended December 2023, United Therapeutics (UTHR) reported revenue of $614.7 million, up 25.1% over the same period last year. EPS came in at$ 4.36, compared to $2.67 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of$ 561.77 million, representing a surprise of +9.42%. The company delivered an EPS surprise of +11.22%, with the consensus EPS estimate being $3.92.While investors scrutinize revenue and earnings changes year-over-year and how they compare with ...